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Abstract
Background: Genetic factors were considered as one of the risk factors for lung cancer or other
cancers. The aim of this work was to determine whether a genetic predisposition accounts for such
familial aggregation of cancer among relatives of lung cancer probands.
Methods: A case-control study was conducted in 800 case families identified by lung cancer
patients (probands), and in 800 control families identified by the probands'spouses. The data were
analysed with logistic regression analysis model.
Results: The data revealed a significantly greater overall risk of cancer (OR = 1.82, P < 0.01) in the
proband group. The relatives of lung cancer probands maintained an increased risk of non-lung
cancer (P < 0.05) after adjusting for confounder factors. The crude odds ratio of a proband family
having one family member with cancer was 1.67 compared with control families. Proband families
were 2.56 times more likely to have two other family members with cancer. For three cancers and
four or more cancers, the risk increased to 3.50 and 5.91, respectively. The most striking
differences in cancer prevalence between proband and control families were noted for cancer risk
among female relatives. The strongest effects were for not only lung cancer in any female relatives
(OR 2.17, 95%CI 1.60–3.64) and mothers (OR 2.78, 95%CI 1.23–5.12) and sisters (OR 2.03, 95%CI
1.26–3.97), but also non-lung cancer in females and mothers (OR 2.00, 95%CI 1.26–3.01, and OR
2.34, 95%CI 1.28–4.40, respectively).
Conclusion: These data support the hypothesis of a genetic susceptibility to cancer in families with
lung cancer, and the female genetic susceptibility to cancer might be greater than male.
Background
Inasmuch as some 22 per cent of all persons die of cancers
affecting various anatomic sites, the random occurrence of
cancer among several members of a nuclear family would
be usual [1]. However, when cancers occur among mem-
bers in several generations of the same family, chance
itself may not be sufficient to account for that occurrence.
An increased familial risk for cancer and particularly lung
cancer has been demonstrated among relatives of lung
cancer patients [2-6]. However, the precise genetic charac-
teristics which influence lung cancer susceptibility are not
known. Many studies of families may be used to attempt
to disentangle the effects of shared environmental risk fac-
tors and genetic factors [7-9].
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However, these conclusions do not address the occasion-
ally observed increased frequency of cancers of several
sites in combination, such as those of the breast, brain,
bone, liver, adrenal cortex, blood, and/or lymphatics[2].
Warthin[10] was the first to describe a large kindred hav-
ing a remarkable high incidence of cancers at various sites.
Pedigree analysis of several large families with multiple
cancers across several generations led Lynch and
Krush[11] to propose a new genetic entity, later called
"cancer family syndrome". In general, those studies
showed that the familial occurrence of cancer tends to
deviate from the Possion distribution, in that more fami-
lies than expected by chance have two or more affected,
closely related members. However, these high-risk fami-
lies were selected for study because of their high frequency
of cancer cases. Because the laws of probability can not
preclude the probability that these cancer families merely
represent a chance occurrence, some investigators have
questioned genetic susceptibility as a basis for familial
aggregation of cancers at various sites.
To explore whether familial aggregation of cancer repre-
sents a random or specific event, we conducted a retro-
spective case-control study of families. The lung cancer
patient (proband) was used to identify a case family and
the proband's spouse was used to identify a control family
in rural regions of Anhui, China.
Methods
Study population
Case-probands were selected if they satisfied a defined eli-
gibility criteria, namely: all farmers who had died of a pri-
mary malignancy of the lung (stated as an underlying
cause of death in their death records) in three counties in
Anhui over a ten-year period (1995–2004). Spouses of
probands were included in the control group if these
spouses were themselves unaffected with lung cancer and
were farmers. The families of probands and controls have
lived in rural regions for over 20-year.
The population of the rural regions in Anhui had almost
little migration 20 years ago and the cultural patterns and
ethnicity have retained definite demographic characteris-
tics. The use of spouse-matched controls can be expected
to control for the potential confouning effects of different
cultural and residential environment, e.g. diet, drinking
water, socioeconomic status and so on.
First-degree relatives (parents, full siblings) of probands
were designated as case families. The control families
comprised first-degree relatives (parents, full siblings) of
the spouses of probands. Thus, in the following sections
of this paper, the term "family", when applied to the study
population, never includes the proband or spouse.
Data collection
A complete listing of all deaths satisfying the eligibility cri-
teria was obtained from the local Tumor Prevention and
Treatment Office of Health Bureau in rural area. Standard
demographic characteristics of the probands and the iden-
tities of their next-of-kin were obtained from the death
records of probands. Local community doctors were
recruited to help initiate contact with family members of
the case-proband. Provided with the identity of the
proband's next-of-kin as well as the usual address of the
deceased, the doctors generated a list of addresses of all
family members in each pedigree.
Trained interviewers with standard protocols obtained
information on each member of the family by face-to-face
interviews from (in order of preference) the involved per-
sons (except the proband or other deceased family mem-
ber), spouse, parent, sibling, or adult offspring. Cancer
histories were verified by two methods: 1) a review of
death certificates on a sample (90.4 and 88.4 percent,
respectively) of relatives of probands and spouses who
were reported to have died in rural regions of Anhui and
2) corroborative information from additional family con-
tacts. Because only first-degree relatives (parent and sib-
lings) were included in the study, bias introduced by
inability to verify all cancer deaths should be mini-
mal[12].
For the protection of human subjects, all of the subjects in
this study signed a consent form according to the guide-
lines of the World Medical Association Declaration of
Helsinki.
Data analysis
Frequency statistics of the study population were com-
puted. Mean age differences between proband and spouse
relatives were tested for signficance using two-sided t tests.
To determine whether the distribution of relatives was
equivalent between study groups, contingency table chis-
quare tests were used. for each family, design variables
were assigned as 1 for the presence and 0 for the absence
of each of the following among the proband's or spouse's
relatives: one, two, three, four or more cancers. Logistic
regression analysis was used to the data to predict whether
a family belonged to the case or control group based on
these design variables. The resulting regression coeffi-
cients (βi)were used to calculate the relative risks of cancer
by the formula: odd ratio = eβi, for the ith variables. To
determine whether differences in environmental exposure
between the case an control families could explain the dif-
ference in cancer occurrence, another logistic model was
fitted to predict cancer occurrence in each family member
based on age, sex, the occupation/industrial exposure
pack-years of tobacco exposure and a variable that
expressed family membership (case or control). BecauseBMC Cancer 2005, 5:146 http://www.biomedcentral.com/1471-2407/5/146
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the excess risk of cancer in the proband families remained
statistically significant, a test of homogeneity was per-
formed to determine whether the study groups differed in
their distribution of cancer types. To isolate where these
differences occurred, contingency chisquare tests were
applied.
Crude odds ratios (OR) were calculated as estimates of the
relative risks, and Woolf's method was used to determine
95% confidence intervals (CI)[13]. Maximum likelihood
estimates of adjusted ORs were obtained from uncondi-
tional logistic regression analysis by the PHREG proce-
dure in SAS software[14].
These variables examined as possible confounders and
effect modifiers included: number of first-degree relatives
(2–4, 5–7, 8–10, >10); smoking status (never, ex-smoker,
current smoker); smoking duration (never, 1–29 yr, 30–
45 yr, >45 yr); amount smoked (none, <20 cigarettes per
day (cpd), 20–30 cpd, 31–40 cpd, >40 cpd); pack-years
(defined as cigarette packs smoked daily multiplied by
years of smoking, gram equivalents of leaf tobacco.
Assuming 1 g per cigarette) of smoking (none, >0–20,
>20–40, >40 pack-years); residence (females only)
(selected three counties vs other counties); age (<55 yr,
55–65 yr, >65 yr); ethnicity (Han vs others); sex, passive
smoking exposure (ever/never and by total years); educa-
tion (through high school vs greater than high school and
by level: none, primary school, middle school, high
school, >high school); martital status (never married,
married, and widowed, divorced or separated); high-risk
industry/occupation (employed in jobs with exposure to
asbestos, benzene, beryllium, bischloromethyl ether,
ceramic dust, talc, chemical fertilizers, chromium or chro-
mates, coke oven emissions, dyes, glues, lacquers, fiber-
glass, cotton dust, insecticides, pesticides, herbicides,
fungicides, isopropyl oil, paint sprays, petroleum prod-
ucts, radioactive materials, vinylchloride or explosives);
the cumulative exposure to smoky coal use for a given
individual was determined by multiplying the annual rate
of smoky coal use times the number of years (coal con-
sumption was generally fixed for the households over the
life cycle of the family and three exposure categories were
formed: >0–70, 70–140, and >140 tons); alcohol con-
sumption (ever/never); vital status; and type of respond-
ent (self/spouse/other); history of COPD (yes/no).
Results
In our study, 800 eligible probands were identified. These
families were only included in the data set once (if there
are more than one cases in a family, the earliest case diag-
nosed was selected as the proband). An average of 2.6 and
2.9 interviews (contacts) were made to complete informa-
tion on each of these proband and spouse families,
respectively. The largest proportion of the contacts was
through siblings, followed closely by spouses. Less than
17 per cent of the contacts were from adult offspring and
surviving parents. The distributions of reported cancer in
relatives by source of contacts were not significantly differ-
ent between proband and spouse families. Information
on complete two-generation pedigrees was obtained for
800 case families and 800 control families. The remaining
families of probands and spouses were excluded from the
analysis because of: inadequate information in names,
addresses, incomplete data on each individual in the ped-
igree (2.8 per cent), or refusals to participate (4.2 per
cent). The resulting sample includes 4,453 case family
members and 4,378 control family members.
Table 1: Characteristics of probands' and spouses' families
Family members and 
characteristic
Proband No. (%) Mean age, yr, of proband Spouse No. (%) Mean age, yr, of spouse
Families 800 800
All relatives 4,453 4,378
Male relatives 2,484(100.0) 2,418(100.0)
Living 1,043(42.0) 56.0 1,064(44.0) 55.3
Dead 1,441(58.0) 49.9 1,354(56.0) 59.4
Female relatives 1,969(100.0) 1,960(100.0)
Living 650(33.0) 57.7 784(40.0) 60.0
Dead 1,319(67.0) 51.0 1,176(60.0) 57.9
Parents 1600(100.0) 1600(100.0)
Livinga 128(8.0) 66.8 192(12.0) 69.0
Dead 1,472(92.0) 60.5 1,408(88.0) 63.1
Siblings 2,853(100.0) 2,778(100.0)
Living 1,883(66.0) 49.0 1,972(71.0) 50.8
Dead 970(34.0) 46.2 806(29.0) 49.0
a P < 0.01, between proportion of relatives in proband and spouse groups who were parents.BMC Cancer 2005, 5:146 http://www.biomedcentral.com/1471-2407/5/146
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A total of 390 case family members(8.76 per cent) and
212 control family members (4.84 per cent) were reported
to have cancer (only primary malignancy counted).
36(9.2 per cent) and 22 (10.4 per cent) were living cancer
cases in the case and control groups, respectively. Of the
cancer deaths reported in the death certificates, 92.8 per
cent were detected by interview. Analogously, 94.2 per
cent of the noncancer deaths were reported. There were no
significant differences in age at death or age of living fam-
ily members with cancer between the two study groups.
Male probands almost numbered equally female
probands by a ratio of 1.12 to 1.05. The mean family size
was similar for both groups, 5.6 including the proband,
and 5.5 including the spouse, respectively. Although more
of the probands were male and more were older than their
spouses, no significant sex or age differences were
observed between the two groups of relatives (table 1).
The proportional distribution of types of relatives, how-
ever, was also non-different between the comparison
groups.
Because the proband families tended to be slightly larger
than spouse families, adjustment was made for the total
number of relatives in the family when determining the
familial risk of cancer. Case families were significantly
more likely to contain at least one family member with
any type of cancer (OR = 1.82, P < 0.01). Each family was
further classified according to the total number of cancers
present among its menbers (none, one, two, three, four or
more). Proband families were 1.67 times more likely to
have one family member with cancer and 2.56 times more
likely to have two family members with cancer than
spouse families(table 2). For three cancers and four or
more cancers, the relative risk increased to 3.50 and 5.91,
respectively. Each risk other than the lastest estimate was
Table 2: Familial risk of developing cancer (all sites) among lung cancer case families and control families
Case Control
Cancers (no.) Families (no.) Relativesa (no.) Ageb (M) Families (no.) Relativesa (no.) Ageb (M) ORc (95% CI)
0 518 2369 627 2598
1 209 902 62.2 143 814 61.8 1.67** (1.22–2.01)
2 51 251 61.0 22 112 60.2 2.56** (1.44–4.29)
3 21 95 62.2 7 37 63.1 3.50** (1.36–10.02)
4+ 4 36 62.4 1 17 63.2 5.91 (0.79–132.10)
** p < 0.01
a Excludes probands and spouses.
b Mean age of members living with or deceased from cancer.
c Represents familial risk of case families, not individual risk, after adjusting for family size, total smoky coal exposure, number of person smoking 
and commune of residence.
Table 3: Familial risk for developing cancer (non-lung cancer and lung cancer)among lung cancer case families and control families
Case Control
Cancers (n.) Families (no.) Relativesa (no.) Families (no.) Relativesa (no.) ORb (95%CI)
Non-lung cancer
0 657 3,591 720 3,865
1 96 568 63 397 1.54(1.17–2.28)**
2 34 194 12 79 1.67 (0.91–3.91)
3 11 83 4 28 2.11 (1.02–7.98)*
4+ 2 17 1 9 3.13 (0.89–60.66)
Lung cancer
0 658 3629 706 3757
1 113 636 81 528 1.48 (1.11–2.02)*
2 17 103 11 77 2.96 (1.44–6.02)**
3 10 69 2 16 5.67 (1.24–34.89)*
4+ 2 16 0 0 --
* p < 0.05. ** p < 0.01.
a Excludes probands and spouses. b Represents familial risk of case families, not individual risk, adjusted for family size, total smoky coal exposure, 
number of person smoking and commune of residence.BMC Cancer 2005, 5:146 http://www.biomedcentral.com/1471-2407/5/146
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significant at the 0.01 level. The average age of those living
family members with cancer, or deceased from cancer, is
also presented. The differences are minimal.
To determine whether this excess risk was evident for can-
cers, we tabulated the total number of cancers in a family
including lung cancer (International Classification of Dis-
eases (ICD), 9th Revision, code nos. 162.0–162.9) (table
3). After adjusting for confounder factors, the overall rela-
tive risk of one member with cancer in case families (OR
1.54) remained statistically significant. The odds ratios for
separate categories also remained significant for families
with three members with cancer. There was a trend of risk
increased for families with more and more members with
cancer. In addition, table 3 significantly shows the
increased risk of lung cancer among relatives of lung can-
cer patients(OR 1.4–5.6, P < 0.05), and the more number
of relatives affected by lung cancer, the greater risk of lung
cancer among the other relatives of lung cancer patients.
The results for the analyses that treated lung cancer, non-
lung cancer and any cancer among relatives of probands
as outcome variables are shown in table 4. Among the
4453 first-degree relatives of the probands, 185 (4.2%)
had a reported diagnosis of lung cancer, and 205 (4.6%)
had a diagnosis of a non-lung cancer. There were 109
(2.5%) lung cancer cases and 103 (2.4%) non-lung cancer
cases among the 4378 first-degree relatives of the spouses.
The strongest effects were for not only lung cancer in any
female relatives (adjusted OR 2.17, 95%CI 1.60–3.64)
and mothers (adjusted OR 2.78, 95%CI 1.23–5.12) and
sisters (adjusted OR 2.03, 95%CI 1.26–3.97), but also
non-lung cancer in females and mothers (OR 2.00,
95%CI 1.26–3.01, and OR 2.34, 95%CI 1.28–4.40,
respectively).
Discussion
In this study, we attempted to control for as many envi-
ronmental risk factors as possible for both the probands
and their relatives in order to understand better the cause
of the observed family aggregation. These data demon-
strate an increase risk of non-lung cancer and lung cancer
specifically among first-degree relatives of lung cancer
probands, and support the hypothesis that genetic factors
play a role in the etiology of lung cancer. Tokuhata and
Lilienfeld[2] provided the first epidemiologic evidence to
support the hypothesis was provided, and reported a sig-
nificantly increased risk of respiration cancer among rela-
tives of lung cancer patients compared to age-, race-, and
sex-matched controls. The risk for cancer in general, how-
ever, was not increased. The present authors[3] recently
reports similar findings. Lynch et al.[5,15] reported on the
familial risk of cancer in relatives of lung cancer probands
and probands with other smoking-related cancers (i.e.
bladder, pancreas, oral cavity). They found no increased
risk for lung cancer when considered separately. However,
the risk for cancers of all anatomic sites was significantly
increased among the relatives of lung cancer probands (p
< 0.001). This increased risk was not evident for relatives
of probands with other smoking-associated cancers, nor
were the cancers themselves smoking-related. The authors
conclude that the data are consistent with the hypothesis
of an underlying susceptibility to malignancy in these
families. Unlike Lynch et al.[5], the present study again
reports an increased risk for lung cancer, and also notes an
increased risk for cancer at several anatomic sites in rela-
tives of lung cancer probands. Even after excluding per-
sons with lung cancer and controlling for the assessed
environmental exposures, a statistically significant excess
risk of cancer was evident.
Our findings also suggest that female relatives (especially
mothers) of lung cancer cases are at higher risk for lung
cancer than male relatives. Previous studies have indicated
that having a first-degree relative with lung cancer was sig-
nificantly associated with lung cancer among non-smok-
ers[3,6,16-18]. Why the apparently stronger association
between lung cancer and lung cancer history in female rel-
Table 4: Risk of cancer for relatives of lung cancer probands and controls
Relatives Lung cancer ORb (95% CI) Non-lung cancer ORb (95% CI) Any cancer ORb (95% CI)
All relativesa 2.05(1.68–2.53)** 1.41(1.08–2.13)* 1.82(1.52–2.02)**
Female relatives 2.17(1.60–3.64)** 2.00(1.26–3.01)** 2.45(1.84–3.20)**
Male relatives 1.33(1.02–2.02)* 1.03(0.78–1.62) 1.36(1.05–1.68)*
Parents 2.90(1.97–4.32)** 1.52(1.01–2.30)* 2.16(1.62–2.87)**
Fathers 2.17 (1.21–3.86)* 1.30(0.86–2.27) 1.80(1.20–2.69)**
Mothers 2.78(1.23–5.12)** 2.34(1.28–4.40)** 3.12(2.03–4.66)**
Siblings 1.65(1.19–2.18)* 1.31(0.97–2.01)* 1.51(1.28–1.80)**
Brothers 1.21(0.79–1.80) 0.92(0.72–1.68) 1.09(0.82–1.49)
Sisters 2.03(1.26–3.97)** 1.98(1.19–3.21)* 2.13(1.58–3.00)**
* p < 0.05 ** p < 0.01
a Excluded probands and spouses. b OR adjusted for family size, commune of residence, birth oder, total smoky coal exposure, pack-years of 
smoking, COPD history, education, age, sex and years of cooking.BMC Cancer 2005, 5:146 http://www.biomedcentral.com/1471-2407/5/146
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atives are unknown. Since certain smoky coal exposure
and cooking habits have been implicated as an important
risk factor for lung cancer among Chinese women[19].
Genetic factors might influence the susceptibility to envi-
ronmental carcingens. Excess of 10 carcinogenic chemi-
cals were identified in cooking and smoky coal fume and
these shown to interact with one another[20,21] and
these possible effects need to be evaluated further.
Findings of familial aggregation and statistical evidence
for a major gene [22-24] have led to the search for high-
penetrant, rare, single genes for lung cancer and low-pen-
etrant, high-frequency, susceptibility genes for lung can-
cer[25]. Some of the most widely and recently studied
polymorphic loci coding for phase I and II enzymes
involved in the activation and conjugation of carcinogen
are cytochrome P4501A1 (CYP1A1), glutathione S-trans-
ferase M1 (GSTM1), myeloperoxidase (MPO), and
NAD(P)H: quinone oxidoreductase (NQO1)[25]. These
genes encoding enzymes that are associated with carcino-
gen metabolism and DNA repair have been the focus of
research into possible susceptibility genes for lung cancer
and othe cancer. Furthermore, the recent findings show
that the homozygous GSTP1 Ile105Val genetype was sig-
nificantly under-represented in NSCLC compared with
controls especially in females, and neither GSTM1 nor
MPO genotypes affected the overall risk of NSCLC, and
the MPO and CYP1A1 risk genotypes interacted to
increase overall risk of NSCLC[26]. Multiple genes of
modest effect interact to confer genomic-based suscepti-
bility to lung cancer. It has been hypothesized that differ-
ences in susceptibility to carcinogens result from an
individual's ability to form genotoxic intermediates, to
detoxify these intermediates, and to repair damaged DNA.
Polymorphisms in genes coding for the enzymes that
drive these processes are likely candidate susceptibility
genes. They could not only increase the lung cancer risk
but also affect the risk of other cancers. Identifying and
testing specific markers using a linkage analysis to confirm
the gene involved in the development and progression of
lung cancer, particularly to explore the interaction of
gene-gene and gene-environment, should be a high future
priority.
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